Abstract
The prognostic value of the immunohistochemical expression of p53 was evaluated in 133 patients with pancreatic cancer. Formalin-fixed paraffin-embedded specimens of ductal pancreatic adenocarcinomas retrieved at the time of operation were stained with the monoclonal antibody DO-7. Approximately half of the tumors (47%) showed a high level of p53 immunoreactivity (> or = 20% positive nuclei). No correlation was demonstrated between the level of p53 immunoreactivity and age of the patient, gender, TNM stage, resectability or site of the tumor. A high level of p53 staining was seen in a slightly smaller proportion (30%) of patients with well-differentiated tumors than in patients with moderately (50%) or poorly differentiated (50%) tumors, but the difference was not significant. In a multivariate survival analysis, stage, grade and postoperative chemotherapy emerged as independent prognostic factors. Surgical resectability, if entered instead of stage as a variable in a separate Cox model, predicted prognosis independently. In univariate analysis, the site of the tumor was also a significant prognostic variable. However, no association between the level of p53 immunoreactivity and survival in either uni- or multivariate analysis ...Continue Reading
Citations
Dec 5, 2000·International Journal of Cancer. Journal International Du Cancer·A KaweshaJ P Neoptolemos
Jun 29, 2001·Nutrition·C J LangerF D Ottery
Aug 12, 1999·BJU International·D J SonneveldD T Sleijfer
Jan 15, 1999·The American Journal of Surgical Pathology·L D ThompsonC S Heffess
Dec 26, 2001·Annals of Surgery·Berthold GerdesDetlef K Bartsch
Feb 2, 2011·Pancreas·Domenico CoppolaHong-Gang Wang
Jan 25, 2013·Pancreas·Sang Hyun ShinYoung-Joo Lee
Mar 9, 2013·Annals of Surgery·Minoru OshimaShinichi Yachida
Jul 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amanda BlackfordRalph H Hruban
Jul 2, 2002·American Journal of Clinical Pathology·Tjarda van HeekRobb E Wilentz
Apr 28, 2005·International Journal of Cancer. Journal International Du Cancer·Anna SivulaAri Ristimäki
Jun 7, 2011·The British Journal of Surgery·D AnsariR Andersson
Mar 28, 2013·Histopathology·Vladislav ZakharovWenqing Cao
Sep 9, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G GarceaD P Berry
Feb 8, 2000·Cancer Treatment Reviews·G H SakorafasG G Tsiotos
Jan 28, 2014·PloS One·Milind JavleDonghui Li
Oct 22, 2014·PloS One·Yiping DuPing Liu
Jun 11, 1999·British Journal of Cancer·Y X HuN Sawabu
Mar 31, 2011·British Journal of Cancer·R A SmithP Ghaneh
Sep 23, 2000·Cancer Control : Journal of the Moffitt Cancer Center·D Coppola
Nov 21, 2007·Expert Opinion on Therapeutic Targets·Giuseppe ToniniDaniele Santini